Filters

See more specimen types...

Other countries

Results: 1 to 20 of 34

Tests names and labsConditionsGenes and analytesMethods

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
4062
  • C Sequence analysis of the entire coding region

Cancer Hotspot Panel

Centogene AG - the Rare Disease Company
Germany
4688
  • E Sequence analysis of select exons

Neuroblastoma, susceptibility to, 3

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neuroblastoma Sequencing Panel with CNV Detection

PreventionGenetics
United States
33
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

ALK. Sequencing of the exons 21-28

Instituto de Medicina Genomica
Spain
11
  • E Sequence analysis of select exons

ALK. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

Hereditary Neuroblastoma via the ALK Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hereditary Cancer Syndrome: Deletion/Duplication Panel

EGL Genetic Diagnostics Eurofins Clinical Diagnostics
United States
11655
  • D Deletion/duplication analysis

CustomNext: Cancer

Ambry Genetics
United States
14668
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BrainTumorNext

Ambry Genetics
United States
7227
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neuroblastoma , Panel Massive Sequencing (NGS) 4 Genes

Reference Laboratory Genetics
Spain
34
  • C Sequence analysis of the entire coding region

Oncology Genetic Panel , Panel Massive Sequencing (NGS) 90 Genes

Reference Laboratory Genetics
Spain
12890
  • C Sequence analysis of the entire coding region

Brain, CNS, and PNS Cancer: Deletion/Duplication Panel

EGL Genetic Diagnostics Eurofins Clinical Diagnostics
United States
1414
  • D Deletion/duplication analysis

VistaSeq Brain/CNS/PNS Cancer Panel

Molecular Diagnostic Laboratory LabCorp
United States
1617
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neuroblastoma Susceptibility to , Sequencing ALK Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Comprehensive Hereditary Cancer Panel

Baylor Miraca Genetics Laboratories
United States
13561
  • E Sequence analysis of select exons

Hereditary Brain, CNS, PNS Cancer Panel

Baylor Miraca Genetics Laboratories
United States
4317
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Brain, CNS, PNS Cancer Panel

Baylor Miraca Genetics Laboratories
United States
4317
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Pediatric Solid Tumors Panel

Invitae
United States
9148
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Familial Neuroblastoma Panel

Invitae
United States
32
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 34

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center